RALYANT
associated with 26 other trademarks
Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous...

Words that describe this trademark:

central nervous system  autoimmune inflammatory diseases  human pharmaceuticals  cardiovascular diseases  inflammatory diseases  disease autoimmune  treatment  diseases  pharmaceuticals 

Serial Number:

85270443

Mark:

RALYANT

Status:

Abandoned-No Statement of Use filed

Status Date:

11-03-2014

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Human pharmaceuticals for the treatment of infectious-related disease, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases; Human pharmaceuticals for use as hemostatic agents

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

08-02-2011

Mark Drawing Status:

Standart Character Mark

Abandon Date:

11-03-2014

Business Name:

JOHNSON & JOHNSON

Correspondent Name:

Recent Trademark filings by this company